PubMed

Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics.

Bois FY.

Environ Health Perspect. 2000 May;108 Suppl 2:275-82.PMID: 10807558 [PubMed - indexed for MEDLINE]Related articlesFree article

Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics.

Bois FY.

Environ Health Perspect. 2000 May;108 Suppl 2:307-16.PMID: 10807560 [PubMed - indexed for MEDLINE]Related articlesFree article

Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.

Hack CE, Chiu WA, Jay Zhao Q, Clewell HJ.

Regul Toxicol Pharmacol. 2006 Oct;46(1):63-83. Epub 2006 Aug 4.PMID: 16889879 [PubMed - indexed for MEDLINE]Related articles

Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach.

Chiu WA, Okino MS, Evans MV.

Toxicol Appl Pharmacol. 2009 Nov 15;241(1):36-60. Epub 2009 Aug 4.PMID: 19660485 [PubMed - indexed for MEDLINE]Related articles

A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.

Cronin WJ 4th, Oswald EJ, Shelley ML, Fisher JW, Flemming CD.

Risk Anal. 1995 Oct;15(5):555-65.PMID: 7501875 [PubMed - indexed for MEDLINE]Related articles

Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.

Evans MV, Chiu WA, Okino MS, Caldwell JC.

Toxicol Appl Pharmacol. 2009 May 1;236(3):329-40. Epub 2009 Feb 26.PMID: 19249323 [PubMed - indexed for MEDLINE]Related articles

Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.

Marino DJ, Clewell HJ, Gentry PR, Covington TR, Hack CE, David RM, Morgott DA.

Regul Toxicol Pharmacol. 2006 Jun;45(1):44-54. Epub 2006 Jan 25.PMID: 16442684 [PubMed - indexed for MEDLINE]Related articles

Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.

Liao KH, Tan YM, Clewell HJ 3rd.

Risk Anal. 2007 Oct;27(5):1223-36.PMID: 18076492 [PubMed - indexed for MEDLINE]Related articles

A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.

Abbas R, Fisher JW.

Toxicol Appl Pharmacol. 1997 Nov;147(1):15-30.PMID: 9356303 [PubMed - indexed for MEDLINE]Related articles

Assessing the reliability of PBPK models using data from methyl chloride-exposed, non-conjugating human subjects.

Jonsson F, Bois FY, Johanson G.

Arch Toxicol. 2001 Jun;75(4):189-99.PMID: 11482516 [PubMed - indexed for MEDLINE]Related articles

Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment.

Clewell HJ 3rd, Gentry PR, Covington TR, Gearhart JM.

Environ Health Perspect. 2000 May;108 Suppl 2:283-305. Review.PMID: 10807559 [PubMed - indexed for MEDLINE]Related articlesFree article

Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.

Mörk AK, Jonsson F, Johanson G.

Toxicol Appl Pharmacol. 2009 Nov 1;240(3):423-32. Epub 2009 Aug 4.PMID: 19660484 [PubMed - indexed for MEDLINE]Related articles

A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.

Fisher JW, Mahle D, Abbas R.

Toxicol Appl Pharmacol. 1998 Oct;152(2):339-59.PMID: 9853003 [PubMed - indexed for MEDLINE]Related articles

Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.

Greenberg MS, Burton GA, Fisher JW.

Toxicol Appl Pharmacol. 1999 Feb 1;154(3):264-78.PMID: 9931286 [PubMed - indexed for MEDLINE]Related articles

Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.

Yokley K, Tran HT, Pekari K, Rappaport S, Riihimaki V, Rothman N, Waidyanatha S, Schlosser PM.

Risk Anal. 2006 Aug;26(4):925-43.PMID: 16948686 [PubMed - indexed for MEDLINE]Related articles

Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.

Marino DJ, Starr TB.

Regul Toxicol Pharmacol. 2007 Dec;49(3):285-300. Epub 2007 Aug 29.PMID: 17949874 [PubMed - indexed for MEDLINE]Related articles

Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach.

Jonsson F, Johanson G.

Toxicol Appl Pharmacol. 2002 Feb 15;179(1):35-49.PMID: 11884235 [PubMed - indexed for MEDLINE]Related articles

Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.

Cox LA Jr.

Environ Health Perspect. 1996 Dec;104 Suppl 6:1413-29.PMID: 9118928 [PubMed - indexed for MEDLINE]Related articlesFree article

Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.

Hack CE.

Toxicology. 2006 Apr 17;221(2-3):241-8. Epub 2006 Feb 8.PMID: 16466842 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics for regulatory risk analysis: the case of trichloroethylene.

Bogen KT.

Regul Toxicol Pharmacol. 1988 Dec;8(4):447-66.PMID: 3222486 [PubMed - indexed for MEDLINE]Related articles